Lisata Therapeutics, Inc.
Lisata Therapeutics, Inc., a pioneering biopharmaceutical company headquartered in the United States, is at the forefront of developing innovative therapies for serious diseases. Founded in 2020, Lisata focuses on advancing its proprietary platform to create targeted treatments that address unmet medical needs, particularly in oncology and autoimmune disorders. With a commitment to scientific excellence, Lisata Therapeutics has achieved significant milestones, including the progression of its lead product candidates through various stages of clinical development. The company’s unique approach combines cutting-edge technology with a deep understanding of disease mechanisms, setting it apart in the competitive biopharmaceutical landscape. As it continues to expand its operational reach, Lisata is poised to make a substantial impact on patient care and therapeutic options in the industry.
DitchCarbon Score
How does Lisata Therapeutics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Lisata Therapeutics, Inc.'s score of 23 is lower than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Lisata Therapeutics, Inc.'s reported carbon emissions
Lisata Therapeutics, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi) or other industry standards. As there are no emissions or reduction initiatives reported, it is unclear how Lisata Therapeutics is addressing climate change or its carbon footprint. The lack of data may suggest that the company is in the early stages of developing its climate strategy or has yet to publicly disclose its environmental impact. In the context of the broader industry, many companies are increasingly focusing on sustainability and setting ambitious targets to reduce their carbon emissions. However, without specific commitments or data, it is difficult to assess Lisata Therapeutics' position in this evolving landscape.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Lisata Therapeutics, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
